Pathophysiology of enteropathogenic Escherichia coli during a host infection.
Lee JB, Kim SK, Yoon JW.
J Vet Sci. 2022 Mar;23(2):e28. doi: 10.4142/jvs.21160. Epub 2022 Jan 27.
Enteropathogenic escherichia coli infection in children.
Ochoa TJ, Contreras CA.
Curr Opin Infect Dis. 2011 Oct;24(5):478-83. doi: 10.1097/QCO.0b013e32834a8b8b.
Updates on defining and detecting diarrheagenic Escherichia coli pathotypes.
Jesser KJ, Levy K.
Curr Opin Infect Dis. 2020 Oct;33(5):372-380. doi: 10.1097/QCO.0000000000000665.
Neonatal Enteropathogenic Escherichia coli Infection Disrupts Microbiota-Gut-Brain Axis Signaling.
Hennessey C, Keogh CE, Barboza M, Brust-Mascher I, Knotts TA, Sladek JA, Pusceddu MM, Stokes P, Rabasa G, Honeycutt M, Walsh O, Nichols R, Reardon C, Gareau MG.
Infect Immun. 2021 Aug 16;89(9):e0005921. doi: 10.1128/IAI.00059-21. Epub 2021 Aug 16.
Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
Serapio-Palacios A, Finlay BB.
Curr Opin Microbiol. 2020 Apr;54:67-76. doi: 10.1016/j.mib.2019.12.001. Epub 2020 Feb 12.
Enteropathogenic Escherichia coli modulates the virulence and pathogenicity of Entamoeba dispar.
Vilela da Silva CA, Costa Dos Santos CE, de Paula Cortezzi MF, Moura CDSS, Cruz RE, Almeida Lopes C, Costa K, Souza LT, Silva PCLD, Neumann E, Nunes ÁC, Gomes MA, Silva Oliveira FM, Caliari MV.
Exp Parasitol. 2024 Jun;261:108750. doi: 10.1016/j.exppara.2024.108750. Epub 2024 Apr 12.
Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.
Olvera A, Carter H, Rajan A, Carlin LG, Yu X, Zeng XL, Shelburne S, Bhatti M, Blutt SE, Shroyer NF, Jenq R, Estes MK, Maresso A, Okhuysen PC.
Clin Infect Dis. 2021 May 18;72(10):e620-e629. doi: 10.1093/cid/ciaa1394.
New insights into the epidemiology of enteropathogenic Escherichia coli infection.
Ochoa TJ, Barletta F, Contreras C, Mercado E.
Trans R Soc Trop Med Hyg. 2008 Sep;102(9):852-6. doi: 10.1016/j.trstmh.2008.03.017. Epub 2008 May 2.
Enteropathogenic Escherichia coli induces Entamoeba histolytica superdiffusion movement on fibronectin by reducing traction forces.
Guo Y, Ye J, Shemesh A, Odeh A, Trebicz-Geffen M, Wolfenson H, Ankri S.
PLoS Pathog. 2025 May 23;21(5):e1012618. doi: 10.1371/journal.ppat.1012618. eCollection 2025 May.
Enteropathogenic Escherichia coli: foe or innocent bystander?
Hu J, Torres AG.
Clin Microbiol Infect. 2015 Aug;21(8):729-34. doi: 10.1016/j.cmi.2015.01.015. Epub 2015 Jan 28.
